Brucellae are gram-negative, facultative intracellular bacteria that can infect many species of animals and man. Six species are recognized within the genus Brucella: B. abortus, B. melitensis, B. suis, B. ovis, B. canis, and B. neotomae (15). This classification is mainly based on differences in pathogenicity and host preference (15). Brucella species and their different biovars are currently distinguished by differential tests based on serotyping, phage typing, dye sensitivity, CO 2 requirement, H 2 S production, and metabolic properties (2, 31). The main pathogenic species worldwide are B. abortus (responsible for bovine brucellosis), B. melitensis (the main etiologic agent of ovine and caprine brucellosis), and B. suis (responsible for swine brucellosis). These three Brucella species may cause abortion in their hosts, which results in huge economic losses.
the most exposed antigenic structure of the Brucella cell surface (5, 10) and has been shown to be an important protective antigen against S Brucella infection in the mouse model, both in active immunization experiments (24, 50) and by passive immunization with monoclonal antibodies (MAbs) (11, 19, 26, 28, 32, 36, 46, 49) . The antigenic determinants involved in serotyping with polyclonal sera are also borne by the O-PS. At present, S Brucella strains are classified into three serotypes, i.e., A ϩ M Ϫ , A Ϫ M ϩ , and A ϩ M ϩ , according to slide agglutination with A and M monospecific polyclonal sera (2) . These agglutination results correspond to strains expressing mainly the A (A dominant) or M (M dominant) antigen or both antigens in nearly equivalent amounts. Additionally, S Brucella strains share common epitopes on the O-PS with cross-reacting strains, of which the most important is Yersinia enterocolitica O:9 (7, 9, 14, 16, 29, 47, 52) . By using MAbs a number of epitope specificities on the O-PS have been reported: A, M, and epitopes shared by both A-and M-dominant strains, which have been named common (C) epitopes (6, 7, 11, 13, 17, 18, 20, 21, 26, 28, 35, 37, 38, (45) (46) (47) . The latter have recently been further subdivided, according to relative preferential MAb binding in enzyme-linked immunosorbent assays (ELISA) to A-and M-dominant biovar 1 strains of B. abortus or B. melitensis and to cross-reacting Y. enterocolitica O:9, into five epitopic specificities: C (MϾA), C (MϭA), C/Y (MϾA), C/Y (MϭA), and C/Y (AϾM) (48) . MAbs indicated as C are specific for Brucella while those indicated as C/Y cross-react with Y. enterocolitica O:9. The preferential binding to A-or M-dominant strains and equal binding to both strains are indicated by AϾM, MϾA, and AϭM, respectively. It has been recently suggested from data of competitions between MAbs that the different O-PS epitopes are probably overlapping structures (48) .
In the present study, we studied the occurrence of the different O-PS epitopes at the surface of representatives of all Brucella species and biovars including the live S vaccine strains by analyzing MAb binding to whole Brucella cells in ELISA and flow cytometry. Our purpose was to determine if some of these epitopes are variably expressed in relation to the serotype and at the Brucella species, biovar, or strain level and in particular if Brucella strains exist that are deficient in the expression of one or more O-PS epitopes. Flow cytometry has recently been used to study the surface exposure of outer membrane protein epitopes in Brucella spp. (5) . It has an advantage over ELISA in allowing study of binding intensity and of the homogeneity or heterogeneity of binding distribution in a cell population.
MATERIALS AND METHODS

Bacteria and cultures.
The strains used in this study are listed in Table 1 . They were from the culture collection of the brucellosis laboratory, Institut National de la Recherche Agronomique, Nouzilly, France. Brucella spp. and Yersinia enterocolitica O:9 cultures were grown for 24 h at 37°C in Roux flasks on tryptic soy agar (Gibco BRL) supplemented with 0.1% (wt/vol) yeast extract (Difco) (TSAYE). For fastidious strains (B. abortus biovar 2 and B. ovis), sterile horse serum (Gibco BRL) was added to TSAYE to a final concentration of 5% (vol/vol) (TSAYES). The Brucella strains were checked for purity, colony phase, and species and biovar characterization by standard procedures (2) . Cells were harvested by flooding the culture surface with phosphate-buffered saline (PBS) (pH 7.4) and were killed by a 1-h incubation at 65°C.
MAbs. MAbs to the Brucella O-PS epitopes were produced and characterized as described previously (10, 13, 26, 28, 47, 48 Flow cytometry. For flow cytometry analysis, 200 l of a suspension (A 600 of 0.4) of heat-killed Brucella or Y. enterocolitica O:9 cells was incubated (1 h, 37°C) with MAbs (hybridoma supernatants diluted twofold in PBS-T) in Eppendorf polystyrene conical vials. After two 0.5-ml PBS-T washes, the cells were incubated (1 h, 37°C) with 200 l of a 1/150 dilution of fluorescein isothiocyanateconjugated goat anti-mouse IgG (heavy plus light chains) serum (Sigma) and then washed twice and resuspended in 0.5 ml of PBS. The suspensions were then filtered through a nylon mesh. Negative controls were bacteria incubated with only the conjugate, and these cells were used to set the acquisition parameters. For data acquisition, the flow cytometer (FACScan; Becton Dickinson, Mountain View, Calif.) was set as follows: detector threshold (FSC-H) ϭ 32; FSC ϭ E00; SSC ϭ 368; parameters, FSC ϭ 5.35 (linear) and SSC-H ϭ 5.55 (linear) and FL1-H 588 (logarithmic scale).
Twenty-thousand Brucella or Yersinia cells were analyzed in each sample. For determination of the mean and median fluorescence values, analyses were performed on ungated (i.e., all) cells. Percentages of cells labeled by each MAb were determined after exclusion of background and nonspecific fluorescence signals by establishing appropriate region markers. Sample analyses were performed with LYSIS II software (Becton Dickinson).
RESULTS
ELISA. (i) A and M epitopes.
In ELISA, anti-O-PS MAb binding levels correlated well with the previously defined epitope specificities and the serotypes defined by polyclonal sera for each Brucella species, biovar, or strain. Indeed, MAb 2C8C4 specific for the A epitope bound preferentially to the A-dominant strains and to strains defined as A ϩ M ϩ , i.e., B. melitensis Ether (biovar 3) and B. suis 40 (biovar 4) ( Table 1) . However, binding of MAb 2C8C4 to the latter strains was, according to the titer, lower than that to the A-dominant strains. Binding to M-dominant strains was not significant or the level was very low (absorbance values around 0.5 at the first 1/10 dilution). Alternatively, MAbs 2E11 and 04F03, specific for the M epitope, showed preferential binding to the Mdominant strains. However, differential levels of binding between the two anti-M MAbs were observed for some strains. In contrast to MAb 2E11, MAb 04F03 showed a significant level of binding to the A-dominant B. melitensis strain 63/9 (biovar 2) and to the A ϩ M ϩ B. melitensis strain Ether (biovar 3) and in a more limited but still significant level of binding to the A-dominant B. suis strains 1330 and S2. Both MAbs also showed a low but significant level of binding to the A-dominant B. abortus strain Tulya (biovar 3). The MAbs specific for the A and M epitopes appeared to be specific for Brucella, as no significant binding or a very low level of binding (for MAb 2C8C4) was observed to Y. enterocolitica O:9 cells. Thus, it appears according to the ELISA results that the distribution of the A and M epitopes defined by MAbs on the different Brucella species, biovars, and strains follows that previously defined by polyclonal sera, but the results also suggest that some differences in the occurrence and abundance of these epitopes between strains may be observed.
(ii) C epitopes. The MAbs specific for the C epitopes could be classified into two groups according to whether they bound to Y. enterocolitica O:9, i.e., C and C/Y. MAbs 12G12 and 07F09, specific for the C (AϭM) epitope, bound at high titers to most A-and M-dominant strains and also to the A ϩ M (48) . MAb 18H08, specific for the C/Y (AϭM) epitope, showed similar levels of binding to all S Brucella species, biovars, and strains studied and thus appeared to recognize an epitope which is the most invariable or most uniformly distributed among S Brucella strains. MAb 04F9, specific for the C/Y (AϾM), epitope, bound significantly to all S Brucella strains studied but at much higher titers to A-dominant and A ϩ M ϩ strains than to M-dominant strains. In contrast, MAb 16C10, specific for the C/Y (MϾA) epitope, bound generally better to M-dominant than to A-dominant strains. Interestingly, the latter MAb showed lower levels of binding to B. suis biovar 2 strains than to the other A-dominant strains studied.
Aside from the observations reported above, it must be noted that the currently used live attenuated S vaccine strains B. abortus B19 (A dominant), B. melitensis Rev.1 (M dominant), and B. suis S2 (A dominant) showed no specific characteristics related to the distribution of the presently defined O-PS epitopes. Indeed, all these strains appear to carry the same epitopes as their representative Brucella biovar reference strain and thus cannot be distinguished from field strains on the basis of their O-PS epitope distribution.
Flow cytometry. (i) A and M epitopes. Flow cytometry showed some results which were contradictory to those obtained by ELISA. In fact, it appeared by flow cytometry that all O-PS epitopes, including the A and M epitopes, are shared to different degrees by S Brucella spp. which nevertheless show a great degree of O-PS heterogeneity among Brucella strains, according to MAb binding intensities and percentages of cells labeled ( Fig. 1) ( Table 2 ). The subdivision of MAb specificities and Brucella serotypes was therefore less evident by flow cytometry than by ELISA. Indeed, MAb 2C8C4, specific for the A epitope, labeled in most cases more than 90% of cells of a Results are expressed as percentages of cells labeled and by the fluorescence intensities (f.i.) at the median (see Fig. 1 ). Minus sign indicates a negative result, i.e., the percentage of cells labeled is lower than that by negative control strain B. ovis 63/290 or B. canis RM6/66 and lower than that labeled by an irrelevant control MAb. The epitope specificities of the MAbs are identified in parentheses.
A-dominant and A ϩ M ϩ strains (Table 2) . However, it also labeled a low but significant percentage (between 30 and 60%) of cells of most M-dominant strains with similar or lower fluorescence intensities. Among the M-dominant strains only B. melitensis Rev.1 (vaccine) was not specifically labeled by MAb 2C8C4. Whereas in ELISA MAb 2C8C4 showed insignificant binding to Y. enterocolitica O:9, this MAb bound strongly to Y. enterocolitica O:9 in flow cytometry (Fig. 1) Thus, it appears from the flow cytometry results that the distribution of the A and M epitopes among S Brucella strains, although following the A or M dominance defined by polyclonal sera, may be rather heterogeneous.
(ii) C epitopes. MAbs 12G12 and 07F09, specific for the C (AϭM) epitope, bound significantly in flow cytometry to most A-dominant, M-dominant, and A ϩ M ϩ Brucella strains. However, the percentage of cells labeled by these MAbs varied between 15 and 95% and did not seem to depend on the A or M dominance of the strains. Indeed, both MAbs labeled a high percentage of cells (around or above 90%) whether the A or M epitope was dominant. But lower percentages of cells from the A-dominant B. melitensis strain 63/9 and the M-dominant B. melitensis strain Rev.1 were labeled (Table 1) . Differences in the levels of binding by MAb 12G12 versus MAb 07F09 were also observed. In particular, whereas MAb 12G12 labeled, depending on the strain, between 15.7 and 89.9% of cells of strains of biovar 2 of B. suis, MAb 07F09 did not bind significantly to any of the same strains (Fig. 1) . The differences in the binding patterns of these MAbs are probably due to differences in affinity, as was previously suggested by competitive ELISA results (54) . Nevertheless, these flow cytometry results confirmed the poor expression of the C (AϭM) epitope in B. suis biovar 2 strains. MAb 12B12, specific for the C (MϾA) epitope, labeled a high percentage of cells of most Brucella strains tested except strains of biovar 2 of B. suis, which is in accordance with the ELISA results. A lower percentage of cells of the A-dominant B. melitensis strain 63/9 was also labeled (38.9%), as was seen with MAbs 12G12 and 07F09. But actually the (MϾA) specificity of MAb 12B12 in ELISA was not observed in flow cytometry, since this MAb bound strongly in flow cytometry to all other A-dominant Brucella strains tested and the binding observed was not significantly different from that observed to M-dominant strains. As in ELISA, MAbs 12G12, 07F09, and 12B12 did not bind significantly to Y. enterocolitica O:9 in flow cytometry (Fig. 1) .
(iii) C/Y epitopes. The remaining MAbs that cross-react with Y. enterocolitica O:9 (MAbs 18H08, 04F9, and 16C10) showed high levels of labeling of Y. enterocolitica O:9 cells (between 94.1 and 99.5% depending on the MAb) comparable to those observed with MAb 2C8C4, specific for the A epitope. These MAbs also bound significantly to all Brucella strains tested and were actually those that showed the highest levels of binding in flow cytometry. In particular, MAb 04F9, specific for the C/Y (AϾM) epitope, showed in comparison to the other MAbs the highest level of binding in flow cytometry to all Brucella strains tested independently of the serotype. This MAb labeled more than 95% of cells in most cases and showed the highest binding fluorescence intensities, in particular to strains of biovar 2 of B. suis and to B. neotomae strain 5K33. The binding capacity of MAb 16C10, specific for the C/Y (MϾA) epitope, in flow cytometry was similar to that of MAb 04F9 except that binding fluorescence intensities were generally slightly lower than those observed for MAb 04F9. This MAb, as did MAb 04F9, seemed to bind equally well to A-and M-dominant Brucella strains. Therefore, the (AϾM) and (MϾA) epitope specificities of MAb 04F9 and MAb 16C10, respectively, demonstrated by ELISA were not evident in flow cytometry.
DISCUSSION
Previously, seven Brucella O-PS epitope specificities have been defined according to preferential binding of MAbs in ELISA to purified S-LPS of the A-dominant B. abortus strain 99, the M-dominant B. melitensis strain Rev.1, and Y. enterocolitica O:9 (48). Competitive binding assays between the MAbs suggested that the different epitopes are probably overlapping structures (48) . A number of previous studies have reported on the distribution of some of the epitopes on A-and M-dominant strains of Brucella species, but none of them really investigated the occurrence of these epitopes on representatives of all recognized Brucella species and their different biovars (6, 13, 17, 21, 22, 35, 37, 38) . ELISA performed with whole Brucella cells in the present study showed that the distribution of the different O-PS epitopes on the different Brucella species and biovars is mostly in accordance with their reported epitope specificities and the serotype defined by polyclonal sera of the Brucella strain considered. However, some differences which are biovar or in some cases strain dependent were observed and in fact contribute to O-PS epitopic heterogeneity at the surface of Brucella spp. In particular, B. suis biovar 2 strains appeared to be devoid of the C (AϭM) and C (MϾA) epitopes. This feature appeared to be specific for B. suis biovar 2 but B. suis biovar 3 strain 686 and B. neotomae 5K33 also showed lower levels of expression of these epitopes according to the MAb titers on these strains. Some discordances were observed between ELISA and flow cytometry results. In fact, MAbs that showed low levels of binding in ELISA to some Brucella strains showed high levels of binding to the same strains in flow cytometry. For instance the MAbs defined as specific for the C/Y (AϾM) and the C/Y (MϾA) epitopes (MAbs 04F9 and 16C10, respectively) showed the highest levels of binding in flow cytometry to all Brucella strains studied, whether A or M-dominant. In contrast to what was observed in ELISA, A-and M-dominant strains were not distinguished by these MAbs in flow cytometry. In previous studies MAb 04F9 (C/Y [AϾM] epitope) was even considered specific for the A epitope by other techniques such as immunoblotting in which this MAb showed absence of binding to M-dominant S-LPS (11, 13, 18, 20, 26) . Probably depending on the technique used, the physical state and presentation of S-LPS or O-PS epitopes are different. It was also previously shown that some MAbs although O-PS specific bound well in ELISA to purified S-LPS but not to purified O-PS (48) . The high level of binding of MAbs observed in flow cytometry and not in ELISA may therefore be due to a better accessibility of the epitope at the surface of bacteria maintained in suspension than on bacteria coated on microtiter plates. Or it may be that expression of coated whole cells on ELISA plates differs from that of whole cells in suspension, probably due to their alteration during binding manipulations (33) . It is also interesting to note that MAb 04F9 afforded good protection in passively immunized BALB/c mice against a virulent challenge of either an A-or an M-dominant Brucella strain (11) . Thus, results of binding in suspension determined by flow cytometry may be a better indication of in vivo binding capacities of MAbs and consequent protection abilities. Another discordance of interest between the ELISA and flow cytometry results was that MAb 2C8C4, specific for the A epitope and previously defined as specific for Brucella, cross-reacted with Y. enterocolitica O:9 in flow cytometry. Flow cytometry showed also that the C (AϭM) epitope on B. suis biovar 2 strains is not completely absent but rather highly deficient. Nevertheless, the apparent absence of the C (MϾA) on B. suis biovar 2 strains seen in ELISA was confirmed by flow cytometry.
The Brucella O-PS structure has been described as being (30) . It was established that antibodies specific for the A epitope require five contiguous ␣-1,2-linked monosaccharide residues for binding (6) . MAb 2C8C4, specific for the A epitope and used in the present study, showed binding characteristics in ELISA that are in agreement with this structural feature. However, its binding in flow cytometry to a significant number of cells of some M-dominant strains suggests that the distribution of the ␣-1,3-linked monosaccharide residues, which in principle should hinder the binding of this MAb, may not always be regular (i.e., one ␣-1,3-linked and four ␣-1,2-linked monosaccharide residues in sequence) on these strains. From the point of view of vaccine development against brucellosis, the results of the present study offer new perspectives. The main problem encountered in animal vaccination with the actual live attenuated S Brucella strains is that vaccinated animals cannot be clearly differentiated from infected animals by the current serological tests, which are based on detection of antibody to S-LPS (29, 52) . S-LPS, and more precisely its O-PS moiety, is indeed immunodominant in S Brucella infections and is considered the best diagnostic antigen for serological diagnosis (16, 52) . To overcome this problem two approaches are at present being considered. The first is to use live attenuated R Brucella strains, in particular the R B. abortus strain RB51 (25, 40, 41, 51) . Since they are devoid of O-PS they should not induce antibody responses against S-LPS which would be detectable by the conventional serological tests or by an ELISA using S-LPS or O-PS as antigen. However, recent studies showed that such R strains are less protective in mice than the current live attenuated S Brucella strains (41, 51) , probably because of the lack of S-LPS. S-LPS and in particular its O-PS moiety have been shown in the mouse model to be important protective antigens against S Brucella infection (11, 19, 24, 26, 28, 32, 36, 46, 49, 50) . Another approach consists of identifying diagnostic protein antigens and deleting the corresponding genes in the current live attenuated S Brucella strains (4). Such constructed mutants should not induce antibody responses against the target protein, which could be used in new diagnostic tests. However, such protein should be immunodominant in infection and be able to detect a percentage of infected animals which is close to that detected by the current serological tests. Up to now antibody responses to protein antigens have been shown to be low and heterogeneous especially in infected cattle (12, 23, 27, 39, 42, 43) . As shown in the present study the occurrence of Brucella strains apparently completely 
